mast therapeutics inc
(MSTX:Consolidated issues listed on NYSE MKT LLC)
Bengt Gustavsson M.D., Ph.D., Prof.
Chairman of Scientific Advisory Board, Mast Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 16 board members in 2 different organizations across 2 different industries.|
See Board Relationships
Mr. Bengt Gustavsson, MD, Ph.D, Prof. is the founder of Isofol Medical and Carmel Pharma. Mr. Gustavsson serves as the Head of Surgical Oncology at Sahlgrenska University Hospital, Göteborg, Sweden. He co-discovered the positive effects of Leucovorin on 5-FU that created the widely used combination treatment against colorectal cancer called 5-FU-LV. He has been the Chairman of Scientific Advisory Board at Mast Therapeutics, Inc. (formerly, Adventrx Pharmaceuticals Inc.) ...
3611 Valley Centre DrivePhone: 858-552-0866
San Diego, California 92130
Board Members Memberships*
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|